Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NUVL
NUVL logo

NUVL News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NUVL News

GSK in Talks to Acquire Cancer Drugmaker Nuvalent for Over $9 Billion

2d agoNewsfilter

Ademi LLP Investigates Nuvalent's Transaction Compliance

14h agoPRnewswire

UK Tech Ecosystem Rebounds with New Growth

23h agoCNBC

Investor Rights Law Firm Investigates Multiple Companies for Potential Violations

1d agoGlobenewswire

US Stocks Close: Nasdaq Hits 5-Week Low Amid Market Rotations

1d agoNASDAQ.COM

Tech Stocks Retreat as DraftKings Soars on SEC Filing

1d agoCNBC

US Stock Market Volatility Amid Falling WTI Crude Prices

1d agoNASDAQ.COM

Investor Alert: Investigations into Multiple Mergers

1d agoGlobenewswire

NUVL Events

No data

No data

NUVL Monitor News

GSK Acquires Nuvalent for $10.6 Billion to Enhance Lung Cancer Portfolio

Jun 09 2026

Nuvalent's Neladalkib NDA Receives FDA Priority Review

Jun 01 2026

Nuvalent's NDA for Zidesamtinib Accepted by FDA, Targeting 2026 Launch

Jan 12 2026

Nuvalent Hits 52-Week High on Promising Data

Nov 17 2025

NUVL Earnings Analysis

No Data

No Data

People Also Watch